Recent Insider Transactions - ADC Therapeutics (NYSE: ADCT)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NYSE ADCT ADC Therapeutics

Redmile Group, LLC / 10 percent owner

12/11/2024

Buy

$3.81

50,000

$191K

15.67M

NYSE ADCT ADC Therapeutics

Redmile Group, LLC / 10 percent owner

12/11/2024

Buy

$2.28

50,000

$114K

15.62M

NYSE ADCT ADC Therapeutics

Redmile Group, LLC / 10 percent owner

12/11/2024

Buy

$3.81

50,000

$191K

13.15M

NYSE ADCT ADC Therapeutics

Redmile Group, LLC / 10 percent owner

12/11/2024

Buy

$2.28

50,000

$114K

13.10M

NYSE ADCT ADC Therapeutics

Zaki Mohamed / officer: Chief Medical Officer

12/06/2024

Sell

$3.13

37,112

$116K

232,888

NYSE ADCT ADC Therapeutics

Kallebo Lisa Michelle / officer: Chief Accounting Officer

12/06/2024

Sell

$3.13

6,503

$20K

35,997

NYSE ADCT ADC Therapeutics

Carmona Jose / officer: Chief Financial Officer

12/06/2024

Sell

$3.13

48,108

$151K

301,892

NYSE ADCT ADC Therapeutics

GRAHAM PETER J / officer: Chief Legal Officer

12/06/2024

Sell

$3.13

41,458

$130K

188,542

NYSE ADCT ADC Therapeutics

MALLIK AMEET / director, officer: Chief Executive Officer

12/06/2024

Sell

$3.13

238,343

$746K

929,005

NYSE ADCT ADC Therapeutics

Redmile Group, LLC / 10 percent owner

12/04/2024

Sell

$2.07

25,352

$52K

15.57M

NYSE ADCT ADC Therapeutics

Redmile Group, LLC / 10 percent owner

12/04/2024

Buy

$2.07

50,672

$105K

15.57M

NYSE ADCT ADC Therapeutics

Redmile Group, LLC / 10 percent owner

12/04/2024

Sell

$2.07

50,672

$105K

15.52M

NYSE ADCT ADC Therapeutics

Redmile Group, LLC / 10 percent owner

12/04/2024

Buy

$2.07

50,672

$105K

13.05M